POPS
CAS No. 321863-21-2
POPS( —— )
Catalog No. M37714 CAS No. 321863-21-2
POPS is a useful organic compound for research related to life sciences. The catalog number is TF0061 and the CAS number is 321863-21-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 132 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePOPS
-
NoteResearch use only, not for human use.
-
Brief DescriptionPOPS is a useful organic compound for research related to life sciences. The catalog number is TF0061 and the CAS number is 321863-21-2.
-
DescriptionPOPS is a useful organic compound for research related to life sciences. The catalog number is TF0061 and the CAS number is 321863-21-2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number321863-21-2
-
Formula Weight784
-
Molecular FormulaC40H75NO10PNa
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC([C@@H](N)COP(OC[C@@H](COC(CCCCCCCCCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)([O-])=O)=O.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cinobufotenine
Cinobufotenine is a parasympathetic ganglia stimulant and is competitively antagonized by hexamethonium.
-
AGN-190299
AGN-190299 is a retinoid prodrug which is converted to its active form.
-
Emoxipine
Emoxipine is an antidepressant agent.The influence of emoxipine (2-ethyl-6-methyl-3-hydroxypyridine hydrochloride) and mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) on the content of lipid peroxidation products in peripheral blood and the dynamics of clinical symptoms of gastrointestinal tract pathology has been studied in patients of middle and senile age with atherosclerosis in the abdominal aorta.
Cart
sales@molnova.com